Clinical Trials Arena on MSN
Mabwell’s mAb leads to 40% reduction in severe COPD exacerbations
A Chinese Phase IIb trial of the mAb has already started, with Mabwell also hoping to initiate a Phase IIa trial in the US.
If you are a COPD patient you may be at risk of flare-ups in the colder months. Check out the expert-approved tips which ...
Unlike the West, where smoking remains the dominant driver, India’s COPD burden is shaped by pollution, says Dr Anurag ...
The new framework, which classifies the severity of exacerbations of COPD based on three key factors was developed by the ...
The GOLD COPD Update 2026 provides updated guidance on case-finding, disease activity, exacerbation management.
According to Dr Shibu Vijayan, Chief Medical Officer, Global Health, Qure.ai, the impact of early COPD diagnosis is profound.
Winter acts as a perfect storm for COPD patients. Cold air irritates the airway lining, causing muscles to tighten and making ...
Winter pollution and cold air can sharply worsen COPD symptoms, especially in non-smokers exposed to biomass smoke. Experts ...
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition that causes breathing difficulties by blocking ...
Chronic obstructive pulmonary disease (COPD) is straining Europe’s healthcare budgets, primarily through preventable ...
COPD remains one of India's most underdiagnosed lung diseases, with millions noticing symptoms only after serious damage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback